Indivior Pharmaceuticals Inc Indivior Pharmaceuticals Inc

Indivior Pharmaceuticals Inc

INDV

Rang in aandelen #3882
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aandeelprijs
$34.01
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$4.24B
Verandering (1 dag)
4.81%
Verandering (1 jaar)
40.02%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Indivior Pharmaceuticals Inc (INDV)
Het dividendrendement (TTM) van Indivior Pharmaceuticals Inc (aandelsymbool: INDV) per 2023-12-31 is: 0.00%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Indivior Pharmaceuticals Inc (INDV) van 2016 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% -100.00%
2016 2.47% 0.00%
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten